Literature DB >> 21173361

Molecular pathways underlying cardiac remodeling during pathophysiological stimulation.

Izhak Kehat1, Jeffery D Molkentin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21173361      PMCID： PMC3076218          DOI： 10.1161/CIRCULATIONAHA.110.942268

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  81 in total

1.  Akt1 is required for physiological cardiac growth.

Authors:  Brian DeBosch; Iya Treskov; Traian S Lupu; Carla Weinheimer; Attila Kovacs; Michael Courtois; Anthony J Muslin
Journal:  Circulation       Date:  2006-04-24       Impact factor: 29.690

2.  Targeted deletion of Puma attenuates cardiomyocyte death and improves cardiac function during ischemia-reperfusion.

Authors:  Ambrus Toth; John R Jeffers; Philip Nickson; Jiang-Yong Min; James P Morgan; Gerard P Zambetti; Peter Erhardt
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-01-06       Impact factor: 4.733

Review 3.  From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease.

Authors:  Alan H Gradman; Fadi Alfayoumi
Journal:  Prog Cardiovasc Dis       Date:  2006 Mar-Apr       Impact factor: 8.194

4.  Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy.

Authors:  Eiki Takimoto; Hunter C Champion; Manxiang Li; Diego Belardi; Shuxun Ren; E Rene Rodriguez; Djahida Bedja; Kathleen L Gabrielson; Yibin Wang; David A Kass
Journal:  Nat Med       Date:  2005-01-23       Impact factor: 53.440

5.  Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial infarction.

Authors:  Patrick Most; Hanna Seifert; Erhe Gao; Hajime Funakoshi; Mirko Völkers; Jörg Heierhorst; Andrew Remppis; Sven T Pleger; Brent R DeGeorge; Andrea D Eckhart; Arthur M Feldman; Walter J Koch
Journal:  Circulation       Date:  2006-09-04       Impact factor: 29.690

6.  Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3 beta activity.

Authors:  Chinmay M Trivedi; Yang Luo; Zhan Yin; Maozhen Zhang; Wenting Zhu; Tao Wang; Thomas Floss; Martin Goettlicher; Patricia Ruiz Noppinger; Wolfgang Wurst; Victor A Ferrari; Charles S Abrams; Peter J Gruber; Jonathan A Epstein
Journal:  Nat Med       Date:  2007-02-18       Impact factor: 53.440

7.  Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice.

Authors:  Gianluigi Condorelli; Alessandra Drusco; Giorgio Stassi; Alfonso Bellacosa; Roberta Roncarati; Guido Iaccarino; Matteo A Russo; Yusu Gu; Nancy Dalton; Clarence Chung; Michael V G Latronico; Claudio Napoli; Junichi Sadoshima; Carlo M Croce; John Ross
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-17       Impact factor: 11.205

8.  Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy.

Authors:  Benjamin J Wilkins; Yan-Shan Dai; Orlando F Bueno; Stephanie A Parsons; Jian Xu; David M Plank; Fred Jones; Thomas R Kimball; Jeffery D Molkentin
Journal:  Circ Res       Date:  2003-12-01       Impact factor: 17.367

9.  Quantitative control of adaptive cardiac hypertrophy by acetyltransferase p300.

Authors:  Jian Qin Wei; Lina A Shehadeh; James M Mitrani; Monica Pessanha; Tatiana I Slepak; Keith A Webster; Nanette H Bishopric
Journal:  Circulation       Date:  2008-08-12       Impact factor: 29.690

10.  Histone acetyltransferase activity of p300 is required for the promotion of left ventricular remodeling after myocardial infarction in adult mice in vivo.

Authors:  Shoichi Miyamoto; Teruhisa Kawamura; Tatsuya Morimoto; Koh Ono; Hiromichi Wada; Yosuke Kawase; Akira Matsumori; Ryosuke Nishio; Toru Kita; Koji Hasegawa
Journal:  Circulation       Date:  2006-02-07       Impact factor: 29.690
View more
  207 in total

Review 1.  Reverse remodeling in heart failure--mechanisms and therapeutic opportunities.

Authors:  Norimichi Koitabashi; David A Kass
Journal:  Nat Rev Cardiol       Date:  2011-12-06       Impact factor: 32.419

Review 2.  Metabolic stress in the myocardium: adaptations of gene expression.

Authors:  Peter A Crawford; Jean E Schaffer
Journal:  J Mol Cell Cardiol       Date:  2012-06-21       Impact factor: 5.000

3.  Genetic Analysis of Connective Tissue Growth Factor as an Effector of Transforming Growth Factor β Signaling and Cardiac Remodeling.

Authors:  Federica Accornero; Jop H van Berlo; Robert N Correll; John W Elrod; Michelle A Sargent; Allen York; Joseph E Rabinowitz; Andrew Leask; Jeffery D Molkentin
Journal:  Mol Cell Biol       Date:  2015-04-13       Impact factor: 4.272

Review 4.  MIF family cytokines in cardiovascular diseases and prospects for precision-based therapeutics.

Authors:  Pathricia V Tilstam; Dake Qi; Lin Leng; Lawrence Young; Richard Bucala
Journal:  Expert Opin Ther Targets       Date:  2017-07       Impact factor: 6.902

5.  Comparison of echocardiographic changes in children with primary hypertension and hypertension due to mild to moderate chronic kidney disease.

Authors:  Gabriel Paris; Sudheer R Gorla; Aura J Arenas-Morales; Wacharee Seeherunvong; Sethuraman Swaminathan
Journal:  Pediatr Nephrol       Date:  2018-10-01       Impact factor: 3.714

6.  Temporal and gefitinib-sensitive regulation of cardiac cytokine expression via chronic β-adrenergic receptor stimulation.

Authors:  Laurel A Grisanti; Ashley A Repas; Jennifer A Talarico; Jessica I Gold; Rhonda L Carter; Walter J Koch; Douglas G Tilley
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-12-05       Impact factor: 4.733

Review 7.  HDAC-dependent ventricular remodeling.

Authors:  Min Xie; Joseph A Hill
Journal:  Trends Cardiovasc Med       Date:  2013-03-15       Impact factor: 6.677

Review 8.  Mathematical modeling of cardiac growth and remodeling.

Authors:  L C Lee; G S Kassab; J M Guccione
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2016-03-07

9.  Curcumin reduces cardiac fibrosis by inhibiting myofibroblast differentiation and decreasing transforming growth factor β1 and matrix metalloproteinase 9 / tissue inhibitor of metalloproteinase 1.

Authors:  Jin Ma; Shi-Yu Ma; Chun-Hua Ding
Journal:  Chin J Integr Med       Date:  2016-03-08       Impact factor: 1.978

Review 10.  Placental growth factor as a protective paracrine effector in the heart.

Authors:  Federica Accornero; Jeffery D Molkentin
Journal:  Trends Cardiovasc Med       Date:  2011-11       Impact factor: 6.677
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.